I
Insight Horizon Media

Why was menomune discontinued?

Author

Christopher Anderson

Published Mar 11, 2026

Why was menomune discontinued?

This decision is based on evolving market dynamics leading to an increased interest in quadrivalent meningococcal conjugate vaccines, as well as on manufacturing challenges with maintaining Menomune® production at the highest quality and regulatory standards in the long term.

Who should not get meningococcal vaccine?

Do not administer meningococcal vaccines to: A person who has ever had a severe allergic reaction (e.g., anaphylaxis) after a previous dose. A person who has a severe allergy to any vaccine component.

What is the difference between Menactra and Menomune?

CDC advisers have recommended that for children ages 2 to 10 at risk for invasive meningococcal disease, the quadrivalent conjugate vaccine Menactra is preferable to the polysaccharide vaccine Menomune.

What are the contraindications of hepatitis B vaccine?

Contraindications to hepatitis A vaccination include a known allergy to any of the vaccine components. Hepatitis B vaccine is contraindicated for individuals with a history of allergic reactions to any of the vaccine’s components. Neither pregnancy nor lactation is a contraindication for use of this vaccine.

Is menomune still used?

A discontinued meningococcal polysaccharide vaccine (MPSV4, Menomune, Sanofi Pasteur) was available in the United States until all doses expired in September 2017. With rare exception, it was not interchangeable with MenACWY conjugate vaccines.

Can the meningococcal vaccine make you sick?

Soreness, redness, or swelling where the shot is given, tiredness, fatigue, headache, muscle or joint pain, fever, chills, nausea, or diarrhea can happen after meningococcal B vaccination. Some of these reactions occur in more than half of the people who receive the vaccine.

Who is at risk for meningococcal disease?

Anyone can get meningococcal disease, but rates of disease are highest in children younger than 1 year old, with a second peak in adolescence. Among teens and young adults, those 16 through 23 years old have the highest rates of meningococcal disease.

What is menomune for?

Menomune® – A/C/Y/W-135, Meningococcal Polysaccharide Vaccine, Groups A, C, Y and W-135 Combined, is indicated for active immunization for the prevention of invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y, and W-135.

Can menactra be given with Pneumovax?

You can administer PCV13 or PPSV23 at the same time as most other routine childhood vaccinations, with one exception. Do not give PCV13 with Menactra®, a meningococcal conjugate vaccine. Children with functional or anatomic asplenia or HIV should NOT receive Menactra® before the age of 2 years.

Which vaccines are contraindicated in immunocompromised patients?

Varicella and zoster vaccines# Varicella-containing vaccines are contraindicated in people who are significantly immunocompromised as a result of a medical condition.

Is fever a contraindication for vaccination?

The presence of a moderate or severe acute illness with or without a fever is a precaution to administration of all vaccines (Table 4-1). The decision to administer or delay vaccination because of a current or recent acute illness depends on the severity of symptoms and etiology of the condition.